These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial. Hamza OJ; Matee MI; Brüggemann RJ; Moshi MJ; Simon EN; Mugusi F; Mikx FH; van der Lee HA; Verweij PE; van der Ven AJ Clin Infect Dis; 2008 Nov; 47(10):1270-6. PubMed ID: 18840077 [TBL] [Abstract][Full Text] [Related]
24. A randomised, double-blind study of itraconazole versus placebo in the treatment and prevention of oral or oesophageal candidosis in patients with HIV infection. Smith D; Midgley J; Gazzard B Int J Clin Pract; 1999; 53(5):349-52. PubMed ID: 10695098 [TBL] [Abstract][Full Text] [Related]
25. Traditional medicines, HIV, and related infections: workshop 2C. Patel M; Bessong P; Liu H Adv Dent Res; 2011 Apr; 23(1):159-64. PubMed ID: 21441498 [TBL] [Abstract][Full Text] [Related]
26. Oral microflora and their relation to risk factors in HIV+ patients with oropharyngeal candidiasis. Sharifzadeh A; Khosravi AR; Shokri H; Asadi Jamnani F; Hajiabdolbaghi M; Ashrafi Tamami I J Mycol Med; 2013 Jun; 23(2):105-12. PubMed ID: 23721997 [TBL] [Abstract][Full Text] [Related]
27. Effect of prolonged HAART on oral colonization with Candida and candidiasis. Yang YL; Lo HJ; Hung CC; Li Y BMC Infect Dis; 2006 Jan; 6():8. PubMed ID: 16423306 [TBL] [Abstract][Full Text] [Related]
28. Comparison of therapeutic activity of fluconazole and itraconazole in the treatment of oesophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study. Barbaro G; Di Lorenzo G Ital J Gastroenterol; 1995 May; 27(4):175-80. PubMed ID: 8520033 [TBL] [Abstract][Full Text] [Related]
29. Resolution of refractory AIDS-related mucosal candidiasis after initiation of didanosine plus saquinavir. Zingman BS N Engl J Med; 1996 Jun; 334(25):1674-5. PubMed ID: 8628377 [No Abstract] [Full Text] [Related]
30. Use of sargramostim (rh-GM-CSF) as adjunctive treatment of fluconazole-refractory oropharyngeal candidiasis in patients with AIDS: a pilot study. Vazquez JA; Hidalgo JA; De Bono S HIV Clin Trials; 2000; 1(3):23-9. PubMed ID: 11590502 [TBL] [Abstract][Full Text] [Related]
31. A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40. Goldman M; Cloud GA; Wade KD; Reboli AC; Fichtenbaum CJ; Hafner R; Sobel JD; Powderly WG; Patterson TF; Wheat LJ; Stein DK; Dismukes WE; Filler SG; ; Clin Infect Dis; 2005 Nov; 41(10):1473-80. PubMed ID: 16231260 [TBL] [Abstract][Full Text] [Related]
32. Erythematous candidosis in patients with complete dentures and HIV+/AIDS. Aleva NA; Birman EG; Afonso W; Chavasco JK; Paula CR; Ribeiro A; Pereira LJ Mycoses; 2007 Sep; 50(5):407-11. PubMed ID: 17714362 [TBL] [Abstract][Full Text] [Related]
33. Dynamic analysis of oral Candida carriage, distribution, and antifungal susceptibility in HIV-infected patients during the first year of highly active antiretroviral therapy in Guangxi, China. Jiang L; Yong X; Li R; Peng Y; Liu W; Qin Q; Zhang L; Liu Z; Liang H; Tao R J Oral Pathol Med; 2014 Oct; 43(9):696-703. PubMed ID: 24931443 [TBL] [Abstract][Full Text] [Related]
34. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. Selwyn PA; Alcabes P; Hartel D; Buono D; Schoenbaum EE; Klein RS; Davenny K; Friedland GH N Engl J Med; 1992 Dec; 327(24):1697-703. PubMed ID: 1359411 [TBL] [Abstract][Full Text] [Related]
35. Oral candidiasis in HIV-infected patients. Brawner DL; Hovan AJ Curr Top Med Mycol; 1995; 6():113-25. PubMed ID: 8724244 [No Abstract] [Full Text] [Related]
36. Clinical case presentations. Oropharyngeal and esophageal candidiasis in HIV disease. AIDS Patient Care STDS; 1997 Feb; 11 Suppl 1():S22-5. PubMed ID: 11361748 [No Abstract] [Full Text] [Related]
37. Topical thymopentin therapy in HIV positive patients with recurrent oral candidiasis: a pilot study. Coppola S; Buccoliero G; Laddago V; Monno L; Perrone A; Guida G; Schiraldi O; Angarano G New Microbiol; 1996 Oct; 19(4):351-5. PubMed ID: 8914137 [TBL] [Abstract][Full Text] [Related]
38. The diagnosis and treatment of candidiasis: current therapeutic options. Filler SG AIDS Patient Care STDS; 1997 Feb; 11 Suppl 1():S10-4; discussion S15. PubMed ID: 11361745 [No Abstract] [Full Text] [Related]
39. [Diagnosis and treatment of infections of the digestive system in HIV-infected patients]. Oktedalen O; Selbekk B; Helle I; Heger B; Serck-Hanssen A; Melby K Tidsskr Nor Laegeforen; 1994 May; 114(12):1416-20. PubMed ID: 8079228 [TBL] [Abstract][Full Text] [Related]
40. Clinical and lymphocyte responses to beta-carotene supplementation in 11 HIV-positive patients with chronic oral candidiasis. Silverman S; Kaugars GE; Gallo J; Thompson JS; Stites DP; Riley WT; Brandt RB Oral Surg Oral Med Oral Pathol; 1994 Oct; 78(4):442-7. PubMed ID: 7800374 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]